Dear Colleagues,
I have the great pleasure in inviting you to the 15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD) to be held from June 26th to 28th, 2015, in Berlin, Germany.
ISVHLD has a long tradition of 43 years. Initially, it focused on the discovery of the hepatitis viruses, then on the development of diagnostic procedures and vaccines as well as on understanding the pathophysiology. Today, therapies have become the focus of research and in 2015 many of the new direct antiviral agents (DAAs) against hepatitis C will be approved. Public Health becomes increasingly important. Identification of patients in need of therapy is a major challenge to make these new therapies accessible to all parts of the world. Furthermore, we still need to develop better and finite therapies for hepatitis B and need to address many more burning issues of global relevance like hepatitis D and E.
This symposium is organized every three years moving around the continents. Basic scientists and clinicians will discuss the most recent advances to combat this very important global health burden caused by all hepatitis viruses. For the first time, this symposium takes place in Germany's capital Berlin.
The 15th ISVHLD will be held together with the 12th Annual Meeting of the German national network of competence on viral hepatitis (Hep-Net) and the 1st International Symposium of the Hepatitis Section of the German Center for Infection Research (DZIF).
It is our vision and ambition to make it a true Global Viral Hepatitis Summit.
We look forward to welcoming you in Berlin in June 2015.
Professor Michael P. Manns, M. D.
President of ISVHLD 2015
Price:
Late Fees - Delegates: EUR 600
Late Fees - Students: EUR 180
Late Fees - Assoziierte der Deutschen Leberstiftung: EUR 300
Late Fees - PI TTU Hepatitis: EUR 300
Speakers: Stanley Lemon (USA), Anna Lok (USA), Ralf Bartenschlager (Germany), Mario Rizzetto (Italy), Mohammed Khuroo (India), Daniel Shouval (Israel), Stephen Locarnini (Australia), Mala Maini (UK), Markus Cornberg (Germany), Stefan Zeuzem (Germany), Alessandra Mangia (Italy), Tarik Asselah (France), Michel Pawlotsky (France), Stephan Urban (Germany), Jeffrey Glenn (USA), Harry Dalton (UK), Nassir Kamar (France), David R. Nelson (USA), Marc Bourli猫re (France), Ulla Protzer (Germany), Florian Klein (USA)
Time: 6:00 am to 5:00 pm
I have the great pleasure in inviting you to the 15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD) to be held from June 26th to 28th, 2015, in Berlin, Germany.
ISVHLD has a long tradition of 43 years. Initially, it focused on the discovery of the hepatitis viruses, then on the development of diagnostic procedures and vaccines as well as on understanding the pathophysiology. Today, therapies have become the focus of research and in 2015 many of the new direct antiviral agents (DAAs) against hepatitis C will be approved. Public Health becomes increasingly important. Identification of patients in need of therapy is a major challenge to make these new therapies accessible to all parts of the world. Furthermore, we still need to develop better and finite therapies for hepatitis B and need to address many more burning issues of global relevance like hepatitis D and E.
This symposium is organized every three years moving around the continents. Basic scientists and clinicians will discuss the most recent advances to combat this very important global health burden caused by all hepatitis viruses. For the first time, this symposium takes place in Germany's capital Berlin.
The 15th ISVHLD will be held together with the 12th Annual Meeting of the German national network of competence on viral hepatitis (Hep-Net) and the 1st International Symposium of the Hepatitis Section of the German Center for Infection Research (DZIF).
It is our vision and ambition to make it a true Global Viral Hepatitis Summit.
We look forward to welcoming you in Berlin in June 2015.
Professor Michael P. Manns, M. D.
President of ISVHLD 2015
Price:
Late Fees - Delegates: EUR 600
Late Fees - Students: EUR 180
Late Fees - Assoziierte der Deutschen Leberstiftung: EUR 300
Late Fees - PI TTU Hepatitis: EUR 300
Speakers: Stanley Lemon (USA), Anna Lok (USA), Ralf Bartenschlager (Germany), Mario Rizzetto (Italy), Mohammed Khuroo (India), Daniel Shouval (Israel), Stephen Locarnini (Australia), Mala Maini (UK), Markus Cornberg (Germany), Stefan Zeuzem (Germany), Alessandra Mangia (Italy), Tarik Asselah (France), Michel Pawlotsky (France), Stephan Urban (Germany), Jeffrey Glenn (USA), Harry Dalton (UK), Nassir Kamar (France), David R. Nelson (USA), Marc Bourli猫re (France), Ulla Protzer (Germany), Florian Klein (USA)
Time: 6:00 am to 5:00 pm
